Lived-Experience Panel for TRANSFORM-TBI
This grant will support new initiative called Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI(TRANSFORM-TBI). In addition to expanding the tissue and imaging archives from the first phase, TRANSFORM-TBI will use samples to investigate why any TBI increases the risk of ADRD, even though brain injuries can vary widely from person to person. Researchers also aim to identify any factors that might increase the risk for developing ADRD.
The team of 26 investigators across 12 sites aims to uncover the type and extent of neuropathological changes that emerge after TBI.
Candace Gant
Candace Gant, our Executive Director has accepted an invitation to be the Keynote Speaker at an upcoming symposium on behalf of the National Neurotrauma Society.
This event, to be held in Philadelphia (June 15-18, 2025), brings together an international community that is dedicated to the study of traumatic brain and spinal cord injuries and engages clinicians, clinician/scientists, and scientists, as well as students, spanning high school to postgraduate research.
MYBF is also waiting to hear about approval on research projects submitted by Moberg Analytics: In summary, the two projects are
Using Case-based Reasoning to Inform Clinical Trajectory of Traumatic Brain Injury
We propose to develop a novel AI algorithm that would use previous patient cases to inform clinical decision making. It would operate much like the Shazam app—given a pattern (audio), find me the closest match (song library), and provide information back to the user (identified song). We’re doing something similar but for patient care in the neuro ICU.
Clinical Test Platform for Validating Non-invasive Neuromonitoring Technology
Every single non-invasive neuromonitoring device must obtain validation data during development for their regulatory approvals; however, there are relatively few solutions that allow device manufacturers to do this easily and at low cost. We propose to build a test platform that allows device manufacturers to validate their devices against invasive devices.